Mercator Medical Sa Stock Fundamentals
MRC Stock | 52.50 1.80 3.55% |
Mercator Medical SA fundamentals help investors to digest information that contributes to Mercator Medical's financial success or failures. It also enables traders to predict the movement of Mercator Stock. The fundamental analysis module provides a way to measure Mercator Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mercator Medical stock.
Mercator |
Mercator Medical SA Company Return On Asset Analysis
Mercator Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mercator Medical Return On Asset | -0.0044 |
Most of Mercator Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mercator Medical SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
Based on the latest financial disclosure, Mercator Medical SA has a Return On Asset of -0.0044. This is 99.95% lower than that of the Healthcare sector and 99.98% lower than that of the Medical Instruments & Supplies industry. The return on asset for all Poland stocks is 96.86% lower than that of the firm.
Mercator Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mercator Medical's current stock value. Our valuation model uses many indicators to compare Mercator Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mercator Medical competition to find correlations between indicators driving Mercator Medical's intrinsic value. More Info.Mercator Medical SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mercator Medical's earnings, one of the primary drivers of an investment's value.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
All Next | Launch Module |
Mercator Fundamentals
Return On Equity | 0.0179 | |||
Return On Asset | -0.0044 | |||
Profit Margin | 0.03 % | |||
Operating Margin | (0.01) % | |||
Current Valuation | 35.23 M | |||
Shares Outstanding | 9.77 M | |||
Shares Owned By Insiders | 64.49 % | |||
Shares Owned By Institutions | 0.39 % | |||
Price To Book | 0.40 X | |||
Price To Sales | 0.60 X | |||
Revenue | 1.73 B | |||
Gross Profit | 725.31 M | |||
EBITDA | 498.66 M | |||
Net Income | 446.87 M | |||
Book Value Per Share | 112.72 X | |||
Cash Flow From Operations | 503 M | |||
Earnings Per Share | 2.63 X | |||
Number Of Employees | 1.47 K | |||
Beta | 2.93 | |||
Market Capitalization | 438.69 M | |||
Total Asset | 1.29 B | |||
Z Score | 1.0 | |||
Net Asset | 1.29 B |
About Mercator Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mercator Medical SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mercator Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mercator Medical SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Mercator Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mercator Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mercator Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Mercator Stock
The ability to find closely correlated positions to Mercator Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mercator Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mercator Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mercator Medical SA to buy it.
The correlation of Mercator Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mercator Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mercator Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mercator Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Mercator Stock Analysis
When running Mercator Medical's price analysis, check to measure Mercator Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mercator Medical is operating at the current time. Most of Mercator Medical's value examination focuses on studying past and present price action to predict the probability of Mercator Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mercator Medical's price. Additionally, you may evaluate how the addition of Mercator Medical to your portfolios can decrease your overall portfolio volatility.